SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-150379
Filing Date
2024-05-30
Accepted
2024-05-30 16:30:50
Documents
3
Period of Report
2024-06-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d777600ddef14a.htm DEF 14A 362301
2 GRAPHIC g777600dsp038.jpg GRAPHIC 125468
3 GRAPHIC g777600dsp039.jpg GRAPHIC 113643
  Complete submission text file 0001193125-24-150379.txt   684339
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Filer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40629 | Film No.: 241005916
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)